HOME |  ABOUT HERBMED |  SPONSORS |  LINKS |  LICENSING |  HELP

 
SCIENTIFIC NAME:
Hydrastis canadensis
FAMILY NAME:
Ranunculaceae/Hydrastidaceae
COMMON NAME:
goldenseal, yellow root, eye root, eye balm, jaundice root, ground raspberry, Indian dye
  Evidence for Efficacy (Human Data)
   Clinical Trials  (4)
   Observational Studies/Case Reports  (1)
   Traditional and Folk Use  (8)
 Safety Data
   Adverse Effects & Toxicity   (1)
   Interactions   (1)
   Contraindications   (0)
  Evidence of Activity
   Animal Studies  (10)
   Pharmacodynamics  (54)
   Analytical Chemistry  (23)
   Pharmacokinetics (ADME)  (3)
   Genetics & Molecular Biology  (6)
 Formulas/Blends
   Contemporary Formulas   (7)
   Folk Blends   (4)
   Patents   (12)
  Other Information
   Pictures & Distribution Maps  (5)
   Cultivation, Conservation & Ecology  (4)
   Related Links  (9)
 Dynamic Updates
   Live PubMed Searches   (15)
  History of Records
   History of Record (1)
 
 
BACK TO HOME
EVIDENCE FOR EFFICACY (HUMAN DATA)
 
Clinical Trials
  SAR of berberines shows that antibacterial activity against Bacillus subtilis and Salmonella enteritidis increased as the length of the C-13 aliphatic side chain increased Iwasa 1998
  Pyrimethamine effect on chloroquine-resistant malaria was increased more by berberine (74%) than by tetracycline (67%) or cotrimoxazole (48%) in a randomized clinical trial with 215 patients Sheng 1997
  Vein tone improvement by 150 mg of procyanidolic oligomers was comparable to that which followed ingestion of a high dose of hamamelis-hydrastis mixture [Article in French] Royer 1981
         A randomized, blinded, controlled trial will be performed to determine the efficacy of herbal therapy and craniosacral manipulation for the prevention of acute otitis media in children with recurrent otitis media. Currently (6/01) recruiting. ClinicalTrials.gov
Observational Studies/Case Reports
  The case of a 32-year-old woman who suffered a phototoxic reaction after taking a dietary supplement containing ginseng, goldenseal, bee pollen, and other ingredients was described. Palanisamy 2003
Traditional and Folk Use
  Berberine alkaloid can be found in the plants of Hydrastis canadensis, Coptis chinensis, Oregon grape, barberry, and tree turmeric. It is used in bacterial diarrhea, intestinal parasite infections, and ocular trachoma infections. [No authors listed] 2000
  The claim that Golden Seal root tea provides false-negative urine drug test is disproved Cone 1998
  Among emergency room patients surveyed for herb use the most common were goldenseal tea, garlic, and ginger Hung 1997
  Only minimal interferences with CEDIA drug screening were seen with golden seal tea lemon juice, Visine, low concentrations of bleach or Drano Wu 1995
         Golden Seal in Mrs. M. Grieve's A Modern Herbal
         Detailed description at David L. Hoffmann's Herbal Materia Medica
         Hydrastis at King's American Dispensatory
         Dan Moerman's Native American Ethnobotany DB
SAFETY DATA
 
Adverse Effects & Toxicity
  Berberine inhibited formation of osteoclast-like multinucleated cells in the co-culture of mouse osteoblastic cells and bone marrow cells Li 1999
Interactions
  Significant herb-drug interactions may result from the concomitant ingestion of goldenseal and CYP3A substrates. Gurley 2007a
Contraindications
No Records
 
EVIDENCE OF ACTIVITY
 
Animal Studies
  A study conducted on the effects of berberine in senescence-accelerated mice P6 (SAMP6) to know whether the alkaloid affects bone mineral density (BMD) revealed that oral administration of berberine (10 mg/kg/d) to male and female mice for 22 weeks resulted in an increase in BMD in both sexes. Li 2003
  Results suggest that medicinal plants like Echinacea or Goldenseal may enhance immune function by increasing antigen-specific immunoglobulin production. Rehman 1999
  Berberine at 0.1 and 0.5 g/kg after 1-2 weeks countered scopolamine induced amnesia in rats. The anti-amnesic effect was augmented by physostigmine or neostigmine Peng 1997
  At 5, 10, and 20 mg/kg i.v. THB increased the ventricular fibrillation threshold, and prevented BaCl2-induced ventricular fibrillation Sun 1993
  THB and its analogues, l-THP and l-SPD, reduced the ligation induced infarct and decreased reperfusion tachycardia and fibrillation. Malondialdehyde and xanthine oxidase activity were also decreased Zhou 1993
  Hyperphagia and polydipsia in streptozotocin diabetic mice is reduced by Arctostaphylos, golden seal (Hydrastis), mistletoe (Viscum) and tarragon (Artemisia) as 6.2% of diet for 9d; not by bayberry (Cinnamomum), meadowsweet (Filipendula) nor senna (Cassia) Swanston-Flatt 1989
  Berberine sulfate, an isoquinoline alkaloid from Hydrastis canadensis, inhibited tumor promoted by TPA, DMBA or teleocidin Nishino 1986
  Effect of some isoquinoline alkaloids on monoamines in the rat brain [Article in Chinese] Liu 1985
  Hydrastine and other isoquinolines inhibited apomorphine-induced rotation in mice. Potency did not correlate with dopamine receptor binding Watanabe 1985
  Hydrastinine and cotarnine derivatives to rats resulted in 18 metabolites in 48-hour urine, mainly isoquinolines of varying degrees of hydrogenation resulting from cleavage of the C-1/C-1' bond, oxygenation, N-dealkylation and O-dealkylation [Article in German] Gober 1979
Pharmacodynamics
  Concomitant administration of homeopathic drugs like Ruta, Hydrastis, Lycopodium and Thuja, retarded the tumor growth and significantly reduced the elevated marker enzymes level as revealed by morphological, biochemical and histopathological evaluation. Kumar 2007
  The root extract of goldenseal, is highly effective in upregulation of liver low density lipoprotein receptor expression in HepG2 cells and in reducing plasma cholesterol and low density lipoprotein cholesterol (LDL-c) in hyperlipidemic hamsters. Abidi 2006
  UVA irradiation of hydrastine, hydrastinine, or canadine (50 microM) did not cause DNA damage or cell death in keratinocytes. Inbaraj 2006
  Goldenseal, at the prescribed human dose, is unlikely to be absorbed to an extent to be unsafe to use in pregnancy despite the apparent cytotoxic effects in vitro. Yao 2005
  The monoclonal antibody against berberine, a bioactive constituent of Coptis japonica M., Phellodendron amurense R. and Hydrastis canadensis L., was produced and characterized. Kim 2004
  Extracts of goldenseal containing berberine and hydrastine, inhibited with increasing potency (CYP2C9) diclofenac 4'-hydroxylation, (CYP2D6) bufuralol 1'-hydroxylation, and (CYP3A4) testosterone 6beta-hydroxylation activities in human hepatic microsomes. Chatterjee 2003
  Among 9 compounds, berberine and to a lesser extent, 2 new C-methyl flavonoids including 6,8-di- C-methylluteolin 7-methyl ether showed antimicrobial activity against Streptococcus mutans and Fusobacterium nucleatum. Hwang 2003
  Methanol extracts of the rhizomes of Sanguinaria canadensis, and the roots and rhizomes of Hydrastis canadensis, two plants used traditionally for the treatment of gastrointestinal ailments, were screened for in vitro antibacterial activity against 15 strains of Helicobacter pylori. Mahady 2003
  UVA irradiation of HaCaT keratinocytes in the presence of 50 microM berberine (a alkaloid of Hydrastis canadensis) resulted in an 80% decrease in cell viability and a 3-fold increase in DNA damage as measured by the Comet assay. Inbaraj 2001
  Berberine, is an alkaloid from Hydrastis canadensis, has positive inotropic, negative chronotropic, antiarrhythmic, and vasodilator properties and has een shown to prolong the duration of ventricular action potential. Lau 2001
  Antibacterial activity of extract and major alkaloids (berberine, hydrastine, canadine and canadaline) of Hydrastis canadensis L. was evaluated against Staphylococcus aureus, Streptococcus sanguis, Escherichia coli and Pseudomonas aeruginosa. Scazzocchio 2001
  This study on the effect of Hydrastis?canadensis alkaloids on precontracted isolated guinea pig tracheahe found EC50 of berberine, beta-hydrastine, canadine and canadaline, were 34.2, 72.8, 11.9 and 2.4microg/ml, respectively. Abdel-Haq 2000
  Berberine is a plant alkaloid present in Hydrastis canadensis with demonstrated antimicrobial activity against bacteria, viruses, fungi, protozoans, helminths, and chlamydia., is used clinically for bacterial diarrhea, intestinal parasite infections, and ocular trachoma infections. Berberine 2000
  Serial dilutions of ethanolic herbal extracts and related pure plant compounds wre analyzed for their in vitro cytochrome P450 3A4 inhibitory effect. A extract of Hydrastis?canadensis was strongly inhibitory, whereas it's major alkaloid, berberine, was not. Budzinski 2000
  The antioxidant activity of Hydrastis?canadensis, obtained using the ABTS assay, used GC-MS for the chemical identification of the antioxidant volatile compounds present in the extracts. Periera da Silva 2000
  Berberine is the component effective against Mycobacterium tuberculosis while canadine, 8-oxotetrahydrothalifendine, beta-hydrastine and two new quinic acid feruloyl esters are inactive Gentry 1998
  Berberrubine, a protoberberine alkaloid which has antitumor activity in animals, has been identified as a specific poison of topoisomerase II in vitro Kim 1998
  Berberine, syringin, limonin & mangiferin inhibit parathyroid hormone (PTH)-stimulated bone resorption in neonatal mouse bone Li 1998
  Protoberberines are dual poisons of topoisomerases I and II. 17 analogs were cytotoxic to cancer cells Sanders 1998
  Berberine inhibited apoptosis induced by dexamethasone, etoposide or camptothecin Miura 1997
  Tetrahydroberberine inhibits outward K+ currents induced by dopamine, acetylcholine, caffeine or strychnine. It does not affect GABA- or glycine-induced Cl- currents, nor non-NMDA receptor agonist-induced cation currents Wu 1997
  l-tetrahydropalmatine (THP), l-stepholidine (SPD), tetrahydroberberine (THB) and tetrahydroproberberine-18 competitively inhibited BE2254 binding to alpha 1-adrenoceptors in rat cerebral cortex with similar affinities [Article in Chinese] Lu 1996
  Molecular modeling of dopamine receptor (based on bacteriorhodopsin) indicates tetrahydroprotoberberine appears to form electrostatic and H-bonding interaction with TM3-Asp and TM5-Ser Tang 1996
  Berberine at 200 micrograms/ml reaches the nucleus and causes signs of apoptosis while 100 micrograms/ml is mainly in the cytoplasm and caused accumulation of cells in G2/M phase instead Yang 1996
  Some effects of berberine, such as its anti-inflammatory action, may stem from the inhibition of DNA-synthesis in activated lymphocytes Ckless 1995
  Berberine induces morphological changes and internucleosomal DNA fragmentation, characteristic of apoptosis in promyelocytic leukemia HL-60 cells Kuo 1995
  THB, THP and SPD (1-100 mumol/L) inhibit the cytosolic calcium rise induced by KCl, extracellular calcium and norepinephrine (effect weaker than verapamil) and had no effect on oubain induced rise [Article in Chinese] Li 1995
  Berberine, palmatine and sanguiritrine inhibited HIV-I reverse transcriptase [Article in Russian] Gudima 1994
  GABA receptor was resistant to competitive GABAA receptor antagonists including bicuculline, hydrastine and SR-95531, and very sensitive to picrotoxin Qian 1994
  Tetrahydroberberine (THB) did not affect GABA nor ACh receptors and did not antagonize convulsant agents [Article in Chinese] Wang 1994
  Tetrahydroberberine (THB) from Corydalis ambigua inhibited rabbit platelet aggregation triggered by arachidonic acid, ADP, or collagen. Also, thromboxane B2 declined Xuan 1994
  Dividing cells, especially repair deficient ones, are sensitive to berberine cytotoxicity, implicating topoisomerase in the mechanism Pasqual 1993
  THB and SPD inhibited KCl induced aorta contractions (IC50 18 micromol/L) but weaker than verapamil Yang 1993
  Tetrahydroberberine (THB) at 10 mumol/L inhibited isoproterenol induced 45Ca uptake in heart mitochondria, dose dependently Zhou 1993
  Berberine is an excellent disinfectant for infective deciduous root canal [Article in Chinese] Su 1992
  Hydrastine, a phthalide isoquinoline, at 0.3% killed 70% of Echinococcus parasitic worms. Disruption of external plasma membrane, hook detachment and sucker deformity of protoscolices were seen by scanning electron microscopy [Article in Chinese] Chen 1991
  THB enhanced barbiturate-induced hypnosis and blocked dopamine-stimulated adenylate cyclase but was not anti-convulsive. THB binds D1 and D2 receptors but not mu-opioid, muscarinic, a2-adrenergic nor benzodiazepine receptors Niwa 1991
  Beta-hydrastine and bicuculline induce positive ionotropic and negative chronotropic effects in rat atria not antagonized by propranolol. Picrotoxin lacks this effect so the mechanism must involve something other than GABAA Bartolini 1990
  Isocoryne, from Corydalis, like other phthalide isoquinoline alkaloids with a 1S,9R isomeric form, inhibit GABA-activated currents with a Ki = 10(-6) M. Chernevskaja 1990
  (+)-Hydrastine has the same 1S,9R configuration as the competitive GABAA antagonist bicuculline and is a more potent convulsant. The enantiomer (-)-hydrastine is much less active Huang 1990
  l-Tetrahydropalmatine (l-THP), tetrahydroberberine (THB) and l-stepholidine (l-SPD), antagonists to central dopamine receptors, enhanced the potency of electroacupuncture analgesia [Article in Chinese] Wu 1990
  l-stepholidine (SPD) was the most potent DA antagonist of12 tetrahydroprotoberberines. It is 18 times more potent than haloperidol for D1 but 14 times weaker for D2 receptors Xu 1989
  Hydrastine treated Echinococcus granulosus (parasitic worm) cysts have microtriche dissolution, microtubule disruption, increased size and number of lysosomes, decreased Golgi complexes and swelling of mitochondria [Article in Chinese] Ye 1989
  The antitussive opiate, noscapine, binds all brain areas, especially the thalamus. Structurally related narceine, hydrastine, narcotoline and papaverine were potent competitors Karlsson 1988
  Golden-seal tea darkens urine which interferes with drug assay Mikkelsen 1988
  Amphetamine-induced ipsilateral rotation were antagonized by THB, l-THP and haloperidol. Scopolamine reversed the antagonism Jin 1986
  Leishmania is inhibited by berberine by interacting with DNA Ghosh 1985
  Fixing the flexible part of TMQ molecule in a tetrahydroprotoberberin configuration reduces the antagonism towards the 48/80 induced histamine release by rat mast cells [Article in German] Belcheva 1984
  Beta-phenylethylamines and the isoquinoline alkaloids. Bentley 1984
  Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors (author's transl) [Article in Chinese] Wang 1982
  Relevance of dopaminergic system to the catalepsy induced by tetrahydroberberine (author's transl)[Article in Chinese] Wang 1981
  Non-adrenergic IPSPs of smooth muscle cells were increased by hydrastine and strychnine and decreased by apamine [Article in Russian] Vladimirova 1978
  A pharmacological study of the alkaloids 1-canadine methochloride and d-tembetarine chloride. Patel 1970
         Bovine mastitis treatment with Echinacea, Goldenseal, Ginseng, Gelsemium, Pokeroot, Aconite and Aloe vera juice; US Patent 5,846,543
Analytical Chemistry
  Desorption electrospray ionization mass spectrometry was investigated to qualitatively identify & quantify analytes directly from developed normal-phase thin-layer chromatography plates using goldenseal and related alkaloids; commercial dietary supplements were used as standards & samples. Van Berkel 2007
  A simple and fast capillary zone electrophoresis method with ultraviolet detection at 225 nm for the quantification of the major goldenseal constituents, berberine and hydrastine, in herbal remedies containing goldenseal root extracts was described. Unger 2005
  A new HPLC method is described and used to show that 5-O-(4'-[beta-d-glucopyranosyl]-trans-feruloyl)quinic acid is a potential marker for goldenseal roots (1.0% w/w) and rhizomes (2.3%). McNamara 2004
  The concentration of hydrastine and berberine, the primary alkaloids in herbal products containing goldenseal was determined. Edwards 2003
  Treatment of hydrastine with the fermentation broth of Polyporous brumalis (ATCC 34487) as a model for mammalian metabolism, gave a new alkaloid, (1S)-hydroxyhydrastine. Structure elucidation was based primarily on NMR and chiroptical studies. Herath 2003
  Goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers were compared for their chemical constituents using Soxhlet extraction, HPLC, GC-MS, and LC-MS analyses. Weber 2003
  A fast, practical ambient extraction methodology followed by isocratic liquid chromatography (LC) analysis with UV detection was validated for the determination of berberine, hydrastine, and canadine in goldenseal (Hydrastis canadensis L.) root powder. Weber 2003
  A rapid, simple and validated high performance liquid chromatographic method, with photodiode array detection, has been developed for the analysis of commercial Goldenseal products. Li 2002
  A HPLC method has been developed for the detection and quantification of hydrastine and berberine in many products obtained from United States market. A wide range of content variation was observed for both alkaloids in the tested samples. Abourashed 2001
  A convenient method for the determination of the quality and possible adulteration of goldenseal products is thin-layer chromatography & TLC results were verified by HPLC analysis. Govindan 2000
  Berberine can be monitored selectively and sensitively with capillary zone electrophoresis at 254 nm within 14 min in the plant extract in a concentration range of 0.1-50 micrograms/ml Liebich 1998
  Isoquinoline alkaloid detection by capillary electrophoresis - mass spectrometry in Hydrastis, Eschscholzia, Berberis, Jateorhiza and Chelidonium Sturm 1998
  [Canadinic Acid: An Alkaloid from Hydrastis canadensis.] Galeffi 1997
  Thermodynamics of DNA interaction with berberine by spectrophotometry shows it is exothermic and dependent on salt concentration Kumar 1993
  Hydrastatinine has been found as a contaminant in 3,4-(methylenedioxy)methylamphetamine (MDMA) [Article in German] Verweij 1991
  Hydrastine, canadine, and berberine determination by the acid-dye technique El-Masry 1980
  Oxyberberine treated with phosphorus oxychloride yields 8-Chloroberberine, an intermediate for other derivatives Moniot 1979
  Studies on the syntheses of heterocyclic compounds. Part 678. Photoracemisation and photoepimerisation of the phthalidylisoquinoline alkaloids (--)-alpha-Narcotine and (--)-beta-Hydrastine. Kametani 1977
  The conversion of berberine into (+/-)-alpha- and (+/-)-beta-hydrastine. Moniot 1976
  Spectrometric determination of the hydrastin content of the rhizome of Hydrastis canadensis L [Article in French] Stanislas 1971
  Studies on the syntheses of heterocyclic compounds. CCCII. Alternative total syntheses of (+ -)-nandinine, (+ -)-canadine, and berberine iodide. Kametani 1969
  The reaction products of narcotinediol and hydrastinediol by SnCl2-HCl [Article in Japanese] Yamaguchi 1969
  Study of fluorescent products obtained during the reaction used for the halofluoric microdetermination of hydrastine. (Application to mixtures: hydrastine-hydrastinine) [Article in French] Anouilh 1966
Pharmacokinetics (ADME)
  Supplementation with the specific formulations of goldenseal or kava kava did not appear to affect digoxin pharmacokinetics, when compared with rifampin and clarithromycin, suggesting the supplements are not potent modulators of P-gp in vivo. Gurley 2007b
  Botanical supplements containing goldenseal strongly inhibited CYP2D6 and CYP3A4/5 activity in vivo, whereas kava inhibited CYP2E1 and black cohosh weakly inhibited CYP2D6. Gurley 2005
  Patients being treated with indinavir can safely take goldenseal root and interactions with other drugs metabolized by CYP3A4 in the liver are unlikely. Sandhu 2003
Genetics & Molecular Biology
  The 5' end of the 26S ribosomal DNA indicates that in Ranunculaceae the Thalictrum chromosome group has 3 independent lineages (1) Hydrastis (2) Xanthorhiza and Coptis (3) Thalictrum, Aquilegia and Enemion Ro 1997
  Berberine and sanguinarine intercalate DNA and inhibit DNA synthesis and reverse transcriptase Schmeller 1997
  NMR shows that berberine and sanguinarine intercalate into DNA Saran 1995
  Circular dichroism studies of DNA with berberine shows increase of 270 nm band but unaffected 240 nm band. Molar ellipticity is larger for AT than GC rich DNA Debnath 1991
  DNA binding studies with berberine indicate it is less deeply intercalated than quinacrine Davidson 1977
         Hydrastis canadensis in Mendel Plant Gene Nomenclature Database
FORMULAS/BLENDS
 
Contemporary Formulas
  Determination of hydrastine in hydrastis fluidextract. Zwaving 1972
  Thin layer chromatography and U. V. spectrphotometry of alcoholic extracts of Hydrastis canadensis Datta 1971
  Assays of hydrastine, hydrastinine and berberine in the liquid extract of hydrastis [Article in Polish] Wisniewski 1970
  Study of the effect of termperature and time on oxidation of hydrastine to hydrastinine in the presence of air oxygen an steam in fluid extract and in rhizoma of Hydrastis canadensis [Article in Polish] Wisniewski 1969
  Inaccuracies of determination of hydrastine by gravimetric method of Ph. P. II in liquid extract of Hydrasts (Extr. Hydrastidis Fl.) [Article in Polish] Wisniewski 1969
  Chromatographic-fluorometric micromethod for assays of hydrastine and hydrastinine in the liquid extract and rhisome of Hydrastis canadensis L [Article in Polish] Wisniewski 1968
  Separation of berberine, hydrastine and hydrastinine from rhizomes of Hydrastis Canadensis and from the liquid extract [Article in Polish] Wisniewski 1966
Folk Blends
         Extract of Hydrastis at King's American Dispensatory
         Compound Infusion of Golden Seal at King's American Dispensatory
         Compound Powder of Golden Seal at King's American Dispensatory
         Tincture of Hydrastis at King's American Dispensatory
Patents
         Conduct a search on "Hydrastis canadensis" or goldenseal in the title, abstract or claims section of the US patent database
         Treating feline-specific disorders by orally administering Hydrastis canadensis US Patent 6,579,542 (Animal)
         Charcoal poultice US Patent 6,353,145
         Anti-fungal composition US Patent 6,495,153
         Hydration compositions for human or animal bodies US Patent 6,207,163
         Method of making an herbal drink US Patent 6,287,567
         Natural composition extracted from plants used in the treatment of cancer US Patent 5,876,728
         Nutritional formula US Patent 5,569,458
         Solution for application to an oral cavity US Patent 5,378,465
         Oral rinse composition US Patent 5,376,374
         Novel composition for treatment of decubitus ulcers US Patent 4,719,111
         Ophthamological use of hydrastis compounds US Patent 3,943,251
OTHER INFORMATION
 
Pictures & Distribution Maps
         US distribution map at BONAP
         Drawing of Hydrastis canadensis at K?r's Medicinal Plants
         Plant picture at Michael Moore
         Plant picture at Michael Moore
         Photo of plant in fruit by Hugh Wilson at TAMU-BWG Digital Library
Cultivation, Conservation & Ecology
  An in vitro propagation protocol for rapidly producing Hydrastis canadensis L., Goldenseal, plantlets from disk tissue of young leaves was developed. Bedir 2003
         NCPMH
         Essays and stuff at NewCROP
         Distribution map, photos, other info in the PLANTS National Database
Related Links
         Detailed description at Chad Bradshaw's Complementary and Alternative Medicine
         Pictures and usage at GreenWeb
         Info at herbweb.com
         Monograph at NCCAM herbs-at-a-Glance
         Search for Hydrastis canadensis in Dr. Duke's Phytochemical and Ethnobotanical Databases. Phytochem and Ethnobot DB
         Description, usage and cultivation info at Plants For A Future
         "Goldenseal's Future," an essay on trade and traditional use of goldenseal by Steven Foster at Steven Foster Group, Inc.
         Goldenseal in Varro E. Tyler's The Honest Herbal
         Information in The HortiPlex Plant Database
DYNAMIC UPDATES
 
Live PubMed Searches
  Hydrastis canadensis and Analytical Chemistry
  Hydrastis canadensis and Animal Studies
  Hydrastis canadensis and Case Reports
  Hydrastis canadensis and Clinical Trials
  Hydrastis canadensis and Drug Interactions
  Hydrastis canadensis and Ethnobotanical Use
  Hydrastis canadensis and Genetics
  Hydrastis canadensis and In Vitro Studies
  Hydrastis canadensis and Pharmacodynamics
  Hydrastis canadensis and Pharmacokinetics
  Hydrastis canadensis and Preparations & Formulary
  Hydrastis canadensis and Reference Standards
  Hydrastis canadensis and Safety & Toxicology
  Hydrastis canadensis and Therapeutic Activity
  Hydrastis canadensis and Tissue Culture

HISTORY OF RECORD
RESEARCHED BY: Soaring Bear, Ph. D.    1998
RESEARCH UPDATED BY: Michael C. Tims, PhD. candidate    March 2003
REVISED BY: J Mohanasundaram, MD, PhD    May 2007
 
BACK TO HOME
 


HerbMed® is copyrighted © 1998-2007 by the Alternative Medicine Foundation, Inc. All rights reserved.
For comments and suggestions, or information on licensing and subscriptions, contact Information Desk.